Table 2.
Article | Joint | Synovial WBC Count Threshold (WBC/μL) | PMN% Threshold | Management of IJD Patients |
---|---|---|---|---|
Spangehl et al. [32] | Hip | 1,100 (SN = 20%, SP = 96%) | 75% (SN = 24%, SP = 89%) | 23 patients with IJD were excluded from analysis |
Kersey et al. [17] | Knee | 2,000 | 50% | >50% PMN seen only in four patients with RA with high rate of false positive |
Mason et al. [20] | Knee | 2,500 (SN = 69%, SP = 98%) | 60% (SN = 76%, SP = 89%) | Analysis included four patients with IJD, however no conclusions were made |
Trampuz et al. [36] | Knee | 1,700 (SN = 94%, SP = 88%) | 65% (SN = 97%, SP = 98%) | Excluded |
Della Valle et al. [4] | Knee | 3,000 (SN = 100%, SP = 98.1%) | 65% (SN = 97.6%, SP = 84.9%) | Excluded |
Schinsky et al. [28] | Hip | 4,200 (SN = 84%, SP = 93%) | 80% (SN = 84%, SP = 82%) | Excluded |
Cipriano et al. [7] | Hip & Knee | 3,444 in IJD (SN = 88.2%, SP = 80.0%) | 75% in IJD (SN = 100%, SP = 81.8%) | Separate and comparative analyses of 61 IJD patients and 810 OA patients |
3450 in OA (SN = 91.0%, SP = 93.0%) | 78% in OA (SN = 95.5%, SP = 87.3%) |
IJD inflammatory joint disease, SN sensitivity, SP specificity